BrightSpring Health Services, Inc. Common Stock (BTSG)vsNational Research Corp (NRC)
BTSG
BrightSpring Health Services, Inc. Common Stock
$57.40
0.00%
HEALTHCARE · Cap: $11.97B
NRC
National Research Corp
$19.75
+3.73%
HEALTHCARE · Cap: $431.35M
Smart Verdict
WallStSmart Research — data-driven comparison
BrightSpring Health Services, Inc. Common Stock generates 9743% more annual revenue ($13.65B vs $138.64M). NRC leads profitability with a 6.5% profit margin vs 2.3%. NRC trades at a lower P/E of 49.1x. BTSG earns a higher WallStSmart Score of 53/100 (C-).
BTSG
Buy53
out of 100
Grade: C-
NRC
Hold48
out of 100
Grade: D+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for BTSG.
Margin of Safety
+50.5%
Fair Value
$27.80
Current Price
$19.75
$8.05 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Earnings expanding 359.8% YoY
Revenue surging 25.6% year-over-year
Every $100 of equity generates 67 in profit
Areas to Watch
2.3% margin — thin
Operating margin of 3.4%
Elevated debt levels
Premium valuation, high expectations priced in
3.7% revenue growth
Smaller company, higher risk/reward
6.5% margin — thin
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : BTSG
The strongest argument for BTSG centers on EPS Growth, Revenue Growth. Revenue growth of 25.6% demonstrates continued momentum.
Bull Case : NRC
The strongest argument for NRC centers on Return on Equity. PEG of 1.32 suggests the stock is reasonably priced for its growth.
Bear Case : BTSG
The primary concerns for BTSG are Profit Margin, Operating Margin, Debt/Equity. A P/E of 79.2x leaves little room for execution misses. Thin 2.3% margins leave little buffer for downturns.
Bear Case : NRC
The primary concerns for NRC are Revenue Growth, Market Cap, Profit Margin. A P/E of 49.1x leaves little room for execution misses. Debt-to-equity of 5.78 is elevated, increasing financial risk.
Key Dynamics to Monitor
BTSG profiles as a growth stock while NRC is a value play — different risk/reward profiles.
BTSG carries more volatility with a beta of 1.87 — expect wider price swings.
BTSG is growing revenue faster at 25.6% — sustainability is the question.
BTSG generates stronger free cash flow (101M), providing more financial flexibility.
Bottom Line
BTSG scores higher overall (53/100 vs 48/100) and 25.6% revenue growth. NRC offers better value entry with a 50.5% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
BrightSpring Health Services, Inc. Common Stock
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
BrightSpring Health Services, Inc. (BTSG) is a leading provider of home and community-based health services, specializing in the care of diverse patient populations, including individuals with intellectual and developmental disabilities and those in need of rehabilitation. The company is committed to delivering personalized, high-quality care through a skilled workforce, which contributes to improved patient outcomes and enhances quality of life. With a focus on strategic investments in innovative technologies and a robust approach to value-based care, BrightSpring is well-positioned to thrive in the dynamic healthcare environment and capitalize on emerging market opportunities.
Visit Website →National Research Corp
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
National Research Corporation provides analytics and information that make it easy to measure and improve the patient and employee experience in the United States and Canada. The company is headquartered in Lincoln, Nebraska.
Compare with Other HEALTH INFORMATION SERVICES Stocks
Want to dig deeper into these stocks?